Loading…

Glycan Determinants of Heparin-Tau Interaction

Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer’s disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little...

Full description

Saved in:
Bibliographic Details
Published in:Biophysical journal 2017-03, Vol.112 (5), p.921-932
Main Authors: Zhao, Jing, Huvent, Isabelle, Lippens, Guy, Eliezer, David, Zhang, Anqiang, Li, Quanhong, Tessier, Peter, Linhardt, Robert J., Zhang, Fuming, Wang, Chunyu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43
cites cdi_FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43
container_end_page 932
container_issue 5
container_start_page 921
container_title Biophysical journal
container_volume 112
creator Zhao, Jing
Huvent, Isabelle
Lippens, Guy
Eliezer, David
Zhang, Anqiang
Li, Quanhong
Tessier, Peter
Linhardt, Robert J.
Zhang, Fuming
Wang, Chunyu
description Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer’s disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little is known about the glycan determinants of this interaction. Here, we used surface plasmon resonance (SPR) and NMR spectroscopy to characterize the interaction between two tau fragments, K18 and K19, and several polysaccharides, including heparin, heparin oligosaccharides, chemically modified heparin, and related glycans. Using a heparin-immobilized chip, SPR revealed that tau K18 and K19 bind heparin with a KD of 0.2 and 70 μM, respectively. In SPR competition experiments, N-desulfation and 2-O-desulfation had no effect on heparin binding to K18, whereas 6-O-desulfation severely reduced binding, suggesting a critical role for 6-O-sulfation in the tau-heparin interaction. The tau-heparin interaction became stronger with longer-chain heparin oligosaccharides. As expected for an electrostatics-driven interaction, a moderate amount of salt (0.3 M NaCl) abolished binding. NMR showed the largest chemical-shift perturbation (CSP) in R2 in tau K18, which was absent in K19, revealing differential binding sites in K18 and K19 to heparin. Dermatan sulfate binding produced minimal CSP, whereas dermatan disulfate, with the additional 6-O-sulfo group, induced much larger CSP. 2-O-desulfated heparin induced much larger CSP in K18 than 6-O-desulfated heparin. Our data demonstrate a crucial role for the 6-O-sulfo group in the tau-heparin interaction, which to our knowledge has not been reported before.
doi_str_mv 10.1016/j.bpj.2017.01.024
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5355497</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006349517301455</els_id><sourcerecordid>1878179916</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxYModq1-AF9kwRd9mDE3kz8TBKFU7RYWfKnPIZPcsRlmM2sys9Bvb9atRfvgUyD3d09OziHkNdAaKMgPQ93th5pRUDWFmjL-hKxAcFZR2sqnZEUplVXDtTgjL3IeKAUmKDwnZ6xlWkkBK1JfjXfOxvVnnDHtQrRxzuupX29wb1OI1Y1d1texzKybwxRfkme9HTO-uj_PyfevX24uN9X229X15cW2cgKaueLS8V5S7RW3XLYdtZ4zz5RooeW9ZRIt8-iUbi2FpnPCogDpOUfGoPO8OSefTrr7pduhdxjnZEezT2Fn052ZbDD_TmK4NT-mgxGNEFyrIvD-JHD7aG1zsTXHu5JfyUOoAxT23f1jafq5YJ7NLmSH42gjTks20KoWlNYgC_r2ETpMS4olit-UElrLo3s4US5NOSfsHxwANcfmzGBKc-bYXDFiSnNl583fP37Y-FNVAT6eACy5HwImk13A6NCHhG42fgr_kf8FTQenIQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1878759964</pqid></control><display><type>article</type><title>Glycan Determinants of Heparin-Tau Interaction</title><source>Open Access: PubMed Central</source><creator>Zhao, Jing ; Huvent, Isabelle ; Lippens, Guy ; Eliezer, David ; Zhang, Anqiang ; Li, Quanhong ; Tessier, Peter ; Linhardt, Robert J. ; Zhang, Fuming ; Wang, Chunyu</creator><creatorcontrib>Zhao, Jing ; Huvent, Isabelle ; Lippens, Guy ; Eliezer, David ; Zhang, Anqiang ; Li, Quanhong ; Tessier, Peter ; Linhardt, Robert J. ; Zhang, Fuming ; Wang, Chunyu</creatorcontrib><description>Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer’s disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little is known about the glycan determinants of this interaction. Here, we used surface plasmon resonance (SPR) and NMR spectroscopy to characterize the interaction between two tau fragments, K18 and K19, and several polysaccharides, including heparin, heparin oligosaccharides, chemically modified heparin, and related glycans. Using a heparin-immobilized chip, SPR revealed that tau K18 and K19 bind heparin with a KD of 0.2 and 70 μM, respectively. In SPR competition experiments, N-desulfation and 2-O-desulfation had no effect on heparin binding to K18, whereas 6-O-desulfation severely reduced binding, suggesting a critical role for 6-O-sulfation in the tau-heparin interaction. The tau-heparin interaction became stronger with longer-chain heparin oligosaccharides. As expected for an electrostatics-driven interaction, a moderate amount of salt (0.3 M NaCl) abolished binding. NMR showed the largest chemical-shift perturbation (CSP) in R2 in tau K18, which was absent in K19, revealing differential binding sites in K18 and K19 to heparin. Dermatan sulfate binding produced minimal CSP, whereas dermatan disulfate, with the additional 6-O-sulfo group, induced much larger CSP. 2-O-desulfated heparin induced much larger CSP in K18 than 6-O-desulfated heparin. Our data demonstrate a crucial role for the 6-O-sulfo group in the tau-heparin interaction, which to our knowledge has not been reported before.</description><identifier>ISSN: 0006-3495</identifier><identifier>EISSN: 1542-0086</identifier><identifier>DOI: 10.1016/j.bpj.2017.01.024</identifier><identifier>PMID: 28297651</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alzheimer's disease ; Biophysics ; Chemical and Process Engineering ; Dose-Response Relationship, Drug ; Engineering Sciences ; Heparin - chemistry ; Heparin - metabolism ; Human health and pathology ; Life Sciences ; Models, Molecular ; Neurons ; Peptide Fragments - chemistry ; Peptide Fragments - metabolism ; Prescription drugs ; Protein Binding - drug effects ; Protein Conformation ; Proteins ; Sodium Chloride - pharmacology ; Spectrum analysis ; Surface Plasmon Resonance ; tau Proteins - chemistry ; tau Proteins - metabolism</subject><ispartof>Biophysical journal, 2017-03, Vol.112 (5), p.921-932</ispartof><rights>2017 Biophysical Society</rights><rights>Copyright © 2017 Biophysical Society. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Biophysical Society Mar 14, 2017</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2017 Biophysical Society. 2017 Biophysical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43</citedby><cites>FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43</cites><orcidid>0000-0002-8236-0901</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355497/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355497/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28297651$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01600157$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Jing</creatorcontrib><creatorcontrib>Huvent, Isabelle</creatorcontrib><creatorcontrib>Lippens, Guy</creatorcontrib><creatorcontrib>Eliezer, David</creatorcontrib><creatorcontrib>Zhang, Anqiang</creatorcontrib><creatorcontrib>Li, Quanhong</creatorcontrib><creatorcontrib>Tessier, Peter</creatorcontrib><creatorcontrib>Linhardt, Robert J.</creatorcontrib><creatorcontrib>Zhang, Fuming</creatorcontrib><creatorcontrib>Wang, Chunyu</creatorcontrib><title>Glycan Determinants of Heparin-Tau Interaction</title><title>Biophysical journal</title><addtitle>Biophys J</addtitle><description>Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer’s disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little is known about the glycan determinants of this interaction. Here, we used surface plasmon resonance (SPR) and NMR spectroscopy to characterize the interaction between two tau fragments, K18 and K19, and several polysaccharides, including heparin, heparin oligosaccharides, chemically modified heparin, and related glycans. Using a heparin-immobilized chip, SPR revealed that tau K18 and K19 bind heparin with a KD of 0.2 and 70 μM, respectively. In SPR competition experiments, N-desulfation and 2-O-desulfation had no effect on heparin binding to K18, whereas 6-O-desulfation severely reduced binding, suggesting a critical role for 6-O-sulfation in the tau-heparin interaction. The tau-heparin interaction became stronger with longer-chain heparin oligosaccharides. As expected for an electrostatics-driven interaction, a moderate amount of salt (0.3 M NaCl) abolished binding. NMR showed the largest chemical-shift perturbation (CSP) in R2 in tau K18, which was absent in K19, revealing differential binding sites in K18 and K19 to heparin. Dermatan sulfate binding produced minimal CSP, whereas dermatan disulfate, with the additional 6-O-sulfo group, induced much larger CSP. 2-O-desulfated heparin induced much larger CSP in K18 than 6-O-desulfated heparin. Our data demonstrate a crucial role for the 6-O-sulfo group in the tau-heparin interaction, which to our knowledge has not been reported before.</description><subject>Alzheimer's disease</subject><subject>Biophysics</subject><subject>Chemical and Process Engineering</subject><subject>Dose-Response Relationship, Drug</subject><subject>Engineering Sciences</subject><subject>Heparin - chemistry</subject><subject>Heparin - metabolism</subject><subject>Human health and pathology</subject><subject>Life Sciences</subject><subject>Models, Molecular</subject><subject>Neurons</subject><subject>Peptide Fragments - chemistry</subject><subject>Peptide Fragments - metabolism</subject><subject>Prescription drugs</subject><subject>Protein Binding - drug effects</subject><subject>Protein Conformation</subject><subject>Proteins</subject><subject>Sodium Chloride - pharmacology</subject><subject>Spectrum analysis</subject><subject>Surface Plasmon Resonance</subject><subject>tau Proteins - chemistry</subject><subject>tau Proteins - metabolism</subject><issn>0006-3495</issn><issn>1542-0086</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kV9rFDEUxYModq1-AF9kwRd9mDE3kz8TBKFU7RYWfKnPIZPcsRlmM2sys9Bvb9atRfvgUyD3d09OziHkNdAaKMgPQ93th5pRUDWFmjL-hKxAcFZR2sqnZEUplVXDtTgjL3IeKAUmKDwnZ6xlWkkBK1JfjXfOxvVnnDHtQrRxzuupX29wb1OI1Y1d1texzKybwxRfkme9HTO-uj_PyfevX24uN9X229X15cW2cgKaueLS8V5S7RW3XLYdtZ4zz5RooeW9ZRIt8-iUbi2FpnPCogDpOUfGoPO8OSefTrr7pduhdxjnZEezT2Fn052ZbDD_TmK4NT-mgxGNEFyrIvD-JHD7aG1zsTXHu5JfyUOoAxT23f1jafq5YJ7NLmSH42gjTks20KoWlNYgC_r2ETpMS4olit-UElrLo3s4US5NOSfsHxwANcfmzGBKc-bYXDFiSnNl583fP37Y-FNVAT6eACy5HwImk13A6NCHhG42fgr_kf8FTQenIQ</recordid><startdate>20170314</startdate><enddate>20170314</enddate><creator>Zhao, Jing</creator><creator>Huvent, Isabelle</creator><creator>Lippens, Guy</creator><creator>Eliezer, David</creator><creator>Zhang, Anqiang</creator><creator>Li, Quanhong</creator><creator>Tessier, Peter</creator><creator>Linhardt, Robert J.</creator><creator>Zhang, Fuming</creator><creator>Wang, Chunyu</creator><general>Elsevier Inc</general><general>Biophysical Society</general><general>The Biophysical Society</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8236-0901</orcidid></search><sort><creationdate>20170314</creationdate><title>Glycan Determinants of Heparin-Tau Interaction</title><author>Zhao, Jing ; Huvent, Isabelle ; Lippens, Guy ; Eliezer, David ; Zhang, Anqiang ; Li, Quanhong ; Tessier, Peter ; Linhardt, Robert J. ; Zhang, Fuming ; Wang, Chunyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Alzheimer's disease</topic><topic>Biophysics</topic><topic>Chemical and Process Engineering</topic><topic>Dose-Response Relationship, Drug</topic><topic>Engineering Sciences</topic><topic>Heparin - chemistry</topic><topic>Heparin - metabolism</topic><topic>Human health and pathology</topic><topic>Life Sciences</topic><topic>Models, Molecular</topic><topic>Neurons</topic><topic>Peptide Fragments - chemistry</topic><topic>Peptide Fragments - metabolism</topic><topic>Prescription drugs</topic><topic>Protein Binding - drug effects</topic><topic>Protein Conformation</topic><topic>Proteins</topic><topic>Sodium Chloride - pharmacology</topic><topic>Spectrum analysis</topic><topic>Surface Plasmon Resonance</topic><topic>tau Proteins - chemistry</topic><topic>tau Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Jing</creatorcontrib><creatorcontrib>Huvent, Isabelle</creatorcontrib><creatorcontrib>Lippens, Guy</creatorcontrib><creatorcontrib>Eliezer, David</creatorcontrib><creatorcontrib>Zhang, Anqiang</creatorcontrib><creatorcontrib>Li, Quanhong</creatorcontrib><creatorcontrib>Tessier, Peter</creatorcontrib><creatorcontrib>Linhardt, Robert J.</creatorcontrib><creatorcontrib>Zhang, Fuming</creatorcontrib><creatorcontrib>Wang, Chunyu</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biophysical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Jing</au><au>Huvent, Isabelle</au><au>Lippens, Guy</au><au>Eliezer, David</au><au>Zhang, Anqiang</au><au>Li, Quanhong</au><au>Tessier, Peter</au><au>Linhardt, Robert J.</au><au>Zhang, Fuming</au><au>Wang, Chunyu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycan Determinants of Heparin-Tau Interaction</atitle><jtitle>Biophysical journal</jtitle><addtitle>Biophys J</addtitle><date>2017-03-14</date><risdate>2017</risdate><volume>112</volume><issue>5</issue><spage>921</spage><epage>932</epage><pages>921-932</pages><issn>0006-3495</issn><eissn>1542-0086</eissn><abstract>Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer’s disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little is known about the glycan determinants of this interaction. Here, we used surface plasmon resonance (SPR) and NMR spectroscopy to characterize the interaction between two tau fragments, K18 and K19, and several polysaccharides, including heparin, heparin oligosaccharides, chemically modified heparin, and related glycans. Using a heparin-immobilized chip, SPR revealed that tau K18 and K19 bind heparin with a KD of 0.2 and 70 μM, respectively. In SPR competition experiments, N-desulfation and 2-O-desulfation had no effect on heparin binding to K18, whereas 6-O-desulfation severely reduced binding, suggesting a critical role for 6-O-sulfation in the tau-heparin interaction. The tau-heparin interaction became stronger with longer-chain heparin oligosaccharides. As expected for an electrostatics-driven interaction, a moderate amount of salt (0.3 M NaCl) abolished binding. NMR showed the largest chemical-shift perturbation (CSP) in R2 in tau K18, which was absent in K19, revealing differential binding sites in K18 and K19 to heparin. Dermatan sulfate binding produced minimal CSP, whereas dermatan disulfate, with the additional 6-O-sulfo group, induced much larger CSP. 2-O-desulfated heparin induced much larger CSP in K18 than 6-O-desulfated heparin. Our data demonstrate a crucial role for the 6-O-sulfo group in the tau-heparin interaction, which to our knowledge has not been reported before.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28297651</pmid><doi>10.1016/j.bpj.2017.01.024</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-8236-0901</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-3495
ispartof Biophysical journal, 2017-03, Vol.112 (5), p.921-932
issn 0006-3495
1542-0086
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5355497
source Open Access: PubMed Central
subjects Alzheimer's disease
Biophysics
Chemical and Process Engineering
Dose-Response Relationship, Drug
Engineering Sciences
Heparin - chemistry
Heparin - metabolism
Human health and pathology
Life Sciences
Models, Molecular
Neurons
Peptide Fragments - chemistry
Peptide Fragments - metabolism
Prescription drugs
Protein Binding - drug effects
Protein Conformation
Proteins
Sodium Chloride - pharmacology
Spectrum analysis
Surface Plasmon Resonance
tau Proteins - chemistry
tau Proteins - metabolism
title Glycan Determinants of Heparin-Tau Interaction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A18%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycan%20Determinants%20of%20Heparin-Tau%20Interaction&rft.jtitle=Biophysical%20journal&rft.au=Zhao,%20Jing&rft.date=2017-03-14&rft.volume=112&rft.issue=5&rft.spage=921&rft.epage=932&rft.pages=921-932&rft.issn=0006-3495&rft.eissn=1542-0086&rft_id=info:doi/10.1016/j.bpj.2017.01.024&rft_dat=%3Cproquest_pubme%3E1878179916%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1878759964&rft_id=info:pmid/28297651&rfr_iscdi=true